Kronox Lab Sciences: Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026
Kronox Lab Sciences (KRONOX) filed a disclosure titled "Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026". The company is valued at about ₹720 crore.
What happened
Kronox Lab Sciences (KRONOX) filed a disclosure with the exchanges on 5 November 2026 at 02:17 PM titled "Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026".
Company snapshot
Kronox Lab Sciences is a micro-cap company, with a market value of about ₹720 crore.
The stock last traded at ₹194, against a 52-week range of ₹96–₹227.7 (14.8% below the high).
Before this filing the shares had moved +0.2% over the month and +21.9% over three months. Average daily turnover over the last 20 sessions was about ₹0.97 crore.
Promoters held 74.21% at the end of Q1 FY27. Foreign institutions owned 0.04% and domestic institutions 2.07%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 24 | 6.3 | 1.7 |
| Q2 FY26 | 26 | 6.7 | 1.82 |
| Q3 FY26 | 25 | 6.6 | 1.79 |
| Q4 FY26 | 26 | 8 | 2.18 |
| Q1 FY27 | 28 | 7.3 | 2 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Kronox Lab Sciences Open Offer Sets ₹150.5 Crore Value
- Kronox Lab Sciences Limited Estimates – NSE:KRONOX
- Kronox Lab Sciences Upper Circuit Today: Price, Data and Peers
- Indo Borax pledges 51.94 lakh Kronox shares for ₹225 crore term loan
- Kronox Lab Sciences Limited (KRONOX.NS) Seasonal returns chart
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.